E-LIB Suche - Ergebnisse für: Dayan, Gustavo H.

1

Efficacy of a monovalent (D614) SARS-CoV-2 recombinant prot..:

Dayan, Gustavo H. ; Rouphael, Nadine ; Walsh, Stephen R....
eClinicalMedicine. 64 (2023) - p. 102168 , 2023

2

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombin..:

Dayan, Gustavo H ; Rouphael, Nadine ; Walsh, Stephen R...
The Lancet Respiratory Medicine. 11 (2023) 11 - p. 975-990 , 2023

Link: https://doi.org/10.1016/..

3

Accuracy and efficacy of pre-dengue vaccination screening f..:

Savarino, Stephen J ; Bonaparte, Matthew ; Wang, Hao...
The Lancet Microbe. 3 (2022) 6 - p. e427-e434 , 2022

Link: https://doi.org/10.1016/..

4

Analysis of Hospitalized and Severe Dengue Cases Over the 6..:

Forrat, Rémi ; Dayan, Gustavo H ; DiazGranados, Carlos A...
Clinical Infectious Diseases. 73 (2021) 6 - p. 1003-1012 , 2021

Link: https://doi.org/10.1093/..

5

Immunobridging efficacy of a tetravalent dengue vaccine aga..:

Huang, Ying ; Moodie, Zoe ; Juraska, Michal...
Transactions of The Royal Society of Tropical Medicine and Hygiene. 115 (2020) 7 - p. 750-763 , 2020

Link: https://doi.org/10.1093/..

6

Efficacy after 1 and 2 doses of CYD-TDV in dengue endemic a..:

Dayan, Gustavo H. ; Langevin, Edith ; Forrat, Remi...
Vaccine. 38 (2020) 41 - p. 6472-6477 , 2020

Link: https://doi.org/10.1016/..

7

Assessment of the long-term efficacy of a dengue vaccine ag..:

Dayan, Gustavo H. ; Langevin, Edith ; Gilbert, Peter B....
Vaccine. 38 (2020) 19 - p. 3531-3536 , 2020

Link: https://doi.org/10.1016/..

8

Measles:

, In: International Encyclopedia of Public Health,

Dayan, Gustavo H. ; McLean, Huong Q. - p. 565-569 , 2017

Link: https://doi.org/10.1016/..

9

Safety Overview of a Recombinant Live-Attenuated Tetravalen..:

Gailhardou, Sophia ; Skipetrova, Anna ; Dayan, Gustavo H....
PLOS Neglected Tropical Diseases. 10 (2016) 7 - p. e0004821 , 2016

Link: https://doi.org/10.1371/..

10

Safety and immunogenicity of three tetravalent dengue vacci..:

Dayan, Gustavo H. ; Thakur, Manoj ; Boaz, Mark.
Vaccine. 31 (2013) 44 - p. 5047-5054 , 2013

Link: https://doi.org/10.1016/..

11

Phase II, dose ranging study of the safety and immunogenici..:

Dayan, Gustavo H. ; Bevilacqua, Joan ; Coleman, Dorothy..
Vaccine. 30 (2012) 47 - p. 6656-6664 , 2012

Link: https://doi.org/10.1016/..

12

Mumps Antibody Levels Among Students Before a Mumps Outbrea..:

Cortese, Margaret M. ; Barskey, Albert E. ; Tegtmeier, Gary E....
The Journal of Infectious Diseases. 204 (2011) 9 - p. 1413-1422 , 2011

Link: https://www.jstor.org/st..

13

Guidance for Isolation Precautions for Mumps in the United ..:

Kutty, Preeta K. ; Kyaw, Moe H. ; Dayan, Gustavo H....
Clinical Infectious Diseases. 50 (2010) 12 - p. 1619-1628 , 2010

Link: https://doi.org/10.1086/..

14

Seroprevalence of Antibody to Mumps Virus in the US Populat..:

Kutty, Preeta K. ; Kruszon‐Moran, Deanna M. ; Dayan, Gustavo H....
The Journal of Infectious Diseases. 202 (2010) 5 - p. 667-674 , 2010

Link: https://doi.org/10.1086/..

15

Seroprevalence of Antibody to Mumps Virus in the US Populat..:

Kutty, Preeta K. ; Kruszon-Moran, Deanna M. ; Dayan, Gustavo H....
The Journal of Infectious Diseases. 202 (2010) 5 - p. 667-674 , 2010

Link: https://www.jstor.org/st..